Search Results - "Tenggardjaja, Christopher F."

Cystectomy for Benign Indications by Aftreth, Owen P., Tenggardjaja, Christopher F., Reyblat, Polina

“…Purpose of Review This article evaluates the historical influences, current use, surgical techniques, and recent evidence on outcomes for cystectomy performed…”
Get full text

Single Institutional Experience with Single Stage Sacral Neuromodulation: Cost Savings and Outcomes in a Contemporary Case Series by Lee, Wai, Artenstein, Daniel, Tenggardjaja, Christopher F, Lee, Una J, Lucioni, Alvaro, Reyblat, Polina, Kobashi, Kathleen C

“…Sacral neuromodulation is traditionally performed in 2 stages. Studies have projected that 1-stage sacral neuromodulation is cost-effective if the conversion…”
Get full text

Combination and Novel Pharmacologic Agents for OAB by Clearwater, Whitney, Kassam, Farzaan, Aalami Harandi, Arshia, Tenggardjaja, Christopher F., Abraham, Nitya

“…Purpose of Review To evaluate recent literature on combination and novel pharmacologic therapies for overactive bladder (OAB). Recent Findings Combination…”
Get full text

Variation in SARS-CoV-2 molecular test sensitivity by specimen types in a large sample of emergency department patients by Bruxvoort, Katia, Tenggardjaja, Christopher F., Slezak, Jeff, Gullett, Jonathan C., Broder, Benjamin, Park, Claire H., Aragones, Michael, Mercado, Cheryl, Wong, Katherine, McLaren, Steven, Jacobsen, Steven J.

“…Provider-collected nasopharyngeal specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) molecular testing are the standard of care in many…”
Get full text

Evaluation of Patients' Perceptions of Mesh Usage in Female Pelvic Medicine and Reconstructive Surgery by Tenggardjaja, Christopher F, Moore, Courtenay K, Vasavada, Sandip P, Li, Jianbo, Goldman, Howard B

“…Objective To evaluate if new patients presenting to a female pelvic medicine and reconstructive surgery clinic are aware of the US Food and Drug Administration…”
Get full text

Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi‐institutional collaboration from the SUFU research network by Reynolds, William Stuart, Suskind, Anne M., Anger, Jennifer T., Brucker, Benjamin M., Cameron, Anne P., Chung, Doreen E., Daignault‐Newton, Stephanie, Lane, Giulia I., Lucioni, Alvaro, Mourtzinos, Arthur P., Padmanabhan, Priya, Reyblat, Polina X., Smith, Ariana L., Tenggardjaja, Christopher F., Lee, Una J.

“…Introduction Onabotulinumtoxin A (BTX‐A) is an effective therapy for overactive bladder (OAB), however, adverse events may prevent patients from initiating…”
Get full text

Advances in Minimally Invasive Repair of Vesicovaginal Fistulas by Tenggardjaja, Christopher F., Goldman, Howard B.

“…Over the past 20 years, the discussion concerning vesicovaginal fistula (VVF) repair has evolved from strictly transabdominal/transvaginal to including…”
Get full text

A Novel Bridging Hand-Assisted LESS Donor Nephrectomy Technique by MAHDAVI, Paymohn, BOWMAN, Ryan J, TENGGARDJAJA, Christopher F, JELLISON, Forrest C, EBRAHIMI, Kamyar Y, DUANE BALDWIN, D

Get full text

Patients with end-stage renal disease are candidates for robot-assisted laparoscopic radical prostatectomy by Heldt, Jonathan P, Jellison, Forrest C, Yuen, Walter D, Tenggardjaja, Christopher F, Lui, Paul D, Ruckle, Herbert C, Barker, Gary R, Baldwin, D Duane

“…Patients with end-stage renal disease (ESRD) have multiple comorbidities that place them at increased risk for surgical complications. Consequently, patients…”
Get more information